SIBN - SI-BONE Medical Trailing Twelve Months Revenue Growth

The 12-month YoY sales growth chart confirms the predictability of cash flows, where the 13.80 level records fresh values. SI-BONE, Inc. (SIBN) revenue stability relies on proprietary sacroiliac joint treatment protocols and physician training. High operational momentum is sustained by the inertia of adoption for minimally invasive implants, which generate a constant inflow of liquidity for the company.
si-bone.com (SIBN) - metric breakdowns and financial figures

Local quality control of implants in the US ensures supply stability for SI-BONE, Inc. (SIBN), which is reflected in the annual sales volume dynamics over the LTM. This indicator calculates revenue growth rates over a rolling twelve-month period, smoothing out seasonal gaps to assess the actual resilience of the business, where any downward trend in the line signals risks of investment capital stagnation.